Numerous clinical trials spanning Early Phase 1 through Phase 4 evaluate hydroxychloroquine sulfate across diverse autoimmune, inflammatory, infectious, and oncological indications, including rheumatoid arthritis, SARS-CoV-2 infection, and prostate cancer. Sponsored predominantly by academic institutions and health systems—such as Dartmouth Cancer Center and Assistance Publique - Hôpitaux de Paris—these studies exhibit varied recruitment statuses ranging from not yet recruiting and active to completed or withdrawn. Together, these investigations highlight broad therapeutic interest in modulating lysosomal and immune pathways.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06652113 | RECRUITING | Recurrent Pregnancy Loss; Euthyroid With Thyroid Antibodies |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-11-15 | |
| NCT07265297 | RECRUITING | Steatohepatitis, Nonalcoholic |
National Taiwan University Hospital |
2025-08-12 | PHASE3 |
| NCT07750067 | RECRUITING | Melanoma Metastatic; NRAS Mutation |
Sun Yat-sen University |
2026-04-01 | PHASE2 |
| NCT07352566 | NOT_YET_RECRUITING | Psoriasis; Atopic Dermatitis |
University of California, San Francisco |
2026-08-01 | PHASE4 |
| NCT05842174 | RECRUITING | Hepatocellular Carcinoma |
VA Office of Research and Development |
2026-04-01 | PHASE1; PHASE2 |
| NCT06389201 | RECRUITING | Nasopharyngeal Carcinoma |
Affiliated Hospital of Nantong University |
2024-08-01 | |
| NCT06676384 | RECRUITING | IgA Nephropathy; Renal Insufficiency, Chronic; IgA Vasculitis; IGA Glomerulonephritis |
Christian Medical College, Vellore, India |
2025-02-15 | PHASE4 |
| NCT05841758 | RECRUITING | Sarcoidosis, Pulmonary |
Hospices Civils de Lyon |
2024-07-30 | PHASE4 |
| NCT07061717 | NOT_YET_RECRUITING | Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2025-07-01 | PHASE3 |
| NCT02714634 | RECRUITING | Rheumatoid Arthritis; Insufficient Response to Methotrexate or Leflunomide |
University Hospital, Strasbourg, France |
2016-03-30 | PHASE4 |
| NCT06408298 | RECRUITING | Resectable Localized Prostate Cancer |
Lionel.D.Lewis, MD |
2026-01-06 | EARLY_PHASE1 |
| NCT05799378 | RECRUITING | Systemic Lupus Erythematosus |
NYU Langone Health |
2024-06-27 | PHASE3 |
| NCT07675291 | NOT_YET_RECRUITING | Lupus Nephritis |
Nanfang Hospital, Southern Medical University |
2026-06 | |
| NCT07557927 | NOT_YET_RECRUITING | Discoid Lupus Erythematosus |
Kunming Pharmaceuticals, Inc. |
2026-04-30 | PHASE2 |
| NCT04381936 | RECRUITING | Pneumonia |
University of Oxford |
2020-03-19 | PHASE3 |
| NCT06971744 | RECRUITING | Ovarian Cancer |
Medical University of South Carolina |
2025-12-18 | PHASE2 |
| NCT03414502 | RECRUITING | Rheumatoid Arthritis |
University of Nebraska |
2007-12-10 | PHASE3 |
| NCT05733000 | RECRUITING | Advanced Biliary Tract Carcinoma; Advanced Colorectal Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma; Advanced Lung Adenocarcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Urothelial Carcinoma; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8; Metastatic Biliary Tract Carcinoma; Metastatic Colorectal Carcinoma; Metastatic Gastroesophageal Junction Adenocarcinoma; Metastatic Lung Adenocarcinoma; Metastatic Ovarian Carcinoma; Metastatic Pancreatic Carcinoma; Metastatic Urothelial Carcinoma; Refractory Biliary Tract Carcinoma; Refractory Colorectal Carcinoma; Refractory Gastroesophageal Junction Adenocarcinoma; Refractory Lung Adenocarcinoma; Refractory Ovarian Carcinoma; Refractory Pancreatic Carcinoma; Refractory Urothelial Carcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8 |
Northwestern University |
2023-03-08 | PHASE2 |
| NCT07138898 | RECRUITING | Rheumatic Disease |
NYU Langone Health |
2025-12-12 | PHASE2 |
| NCT06350630 | RECRUITING | IgA Nephropathy |
Centre Hospitalier Universitaire de Saint Etienne |
2025-06-26 | PHASE2 |
| NCT04523857 | RECRUITING | Breast Cancer |
Abramson Cancer Center at Penn Medicine |
2021-11-01 | PHASE2 |
| NCT07467252 | NOT_YET_RECRUITING | Pulmonary Tuberculosis |
Ministry of Health, Saudi Arabia |
2026-09 | PHASE2 |
| NCT07230028 | NOT_YET_RECRUITING | Lyme Borreliosis, Nervous System |
Radboud University Medical Center |
2027-03-01 | PHASE4 |
| NCT07443436 | NOT_YET_RECRUITING | Interstitial Lung Disease |
Assistance Publique - Hôpitaux de Paris |
2026-10-01 | PHASE2 |
| NCT07343635 | RECRUITING | Erythematotelangiectatic Rosacea |
The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
2026-02-01 | |
| NCT04841148 | RECRUITING | Breast Cancer |
Abramson Cancer Center at Penn Medicine |
2021-06-01 | PHASE2 |
| NCT04911816 | RECRUITING | Adenocarcinoma of the Pancreas |
West Virginia University |
2021-07-16 | PHASE1; PHASE2 |
| NCT03598595 | ACTIVE_NOT_RECRUITING | Recurrent Osteosarcoma; Refractory Osteosarcoma |
M.D. Anderson Cancer Center |
2019-01-28 | PHASE1; PHASE2 |
| NCT05036226 | RECRUITING | Prostate Cancer Recurrent; Solid Tumor, Adult |
Medical University of South Carolina |
2022-03-03 | PHASE1; PHASE2 |
| NCT06949982 | RECRUITING | Metastatic Colorectal Cancer (mCRC); Colorectal Neoplasms |
Sergey Orlov, MD |
2025-03-17 | PHASE2 |
| NCT04316169 | WITHDRAWN | Solid Tumor; Advanced Breast Cancer |
Medical College of Wisconsin |
2021-10-21 | PHASE1 |
| NCT05041907 | RECRUITING | COVID-19 |
University of Oxford |
2021-09-30 | PHASE2 |
| NCT06519617 | ENROLLING_BY_INVITATION | Primary Sjögren Syndrome |
Qingwen Tao |
2024-07-13 | PHASE2 |
| NCT05287321 | RECRUITING | Preeclampsia |
Yoo-min Kim |
2022-05-31 | PHASE3 |
| NCT06862284 | NOT_YET_RECRUITING | Primary Sjögren's Syndrome (pSS) |
Peking University People's Hospital |
2025-03-10 | PHASE2 |
| NCT05843188 | ACTIVE_NOT_RECRUITING | Metastatic Colorectal Cancer |
University Health Network, Toronto |
2023-08-09 | PHASE2 |
| NCT04678648 | RECRUITING | Advanced Malignant Solid Neoplasm; RAS Mutation; Lung Cancer; Colon Cancer; Glioblastoma; Pancreatic Cancer |
RasCal Therapeutics, Inc. |
2021-03-03 | PHASE1 |
| NCT06229340 | RECRUITING | RAS Mutation; Ras (Kras or Nras) Gene Mutation; Colorectal Cancer Recurrent; Pancreas Cancer; Lung Cancer; Melanoma; Refractory Cancer |
N.N. Petrov National Medical Research Center of Oncology |
2023-10-03 | PHASE2 |
| NCT04532346 | RECRUITING | Interstitial Lung Disease; Surfactant Dysfunction |
Children's Hospital of Fudan University |
2024-09-01 | EARLY_PHASE1 |
| NCT06816810 | NOT_YET_RECRUITING | Parkinson&Amp;#39;s Disease |
Ottawa Hospital Research Institute |
2025-03 | PHASE2 |
| NCT04464759 | ACTIVE_NOT_RECRUITING | Melanoma |
Ravi Amaravadi, MD |
2020-10-21 | PHASE1; PHASE2 |
| NCT05279027 | ACTIVE_NOT_RECRUITING | Melanoma (Skin) |
Abramson Cancer Center at Penn Medicine |
2022-03-08 | EARLY_PHASE1 |
| NCT04354649 | RECRUITING | Arthritis; Arthralgia |
AHS Cancer Control Alberta |
2021-09-16 | PHASE2 |
| NCT06319560 | RECRUITING | Diabetes in Pregnancy; Type 2 Diabetes |
National University of Malaysia |
2024-03-24 | |
| NCT06768294 | NOT_YET_RECRUITING | Calcium Pyrophosphate Deposition Disease; Chondrocalcinosis |
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
2025-01 | PHASE2 |
| NCT06467526 | NOT_YET_RECRUITING | Sudden Hearing Loss |
Chang Gung Memorial Hospital |
2024-07-01 | PHASE2 |
| NCT04201457 | ACTIVE_NOT_RECRUITING | Low Grade Glioma (LGG) of Brain With BRAF Aberration; High Grade Glioma (HGG) of the Brain With BRAF Aberration; Low Grade Glioma of Brain With Neurofibromatosis Type 1 |
Pediatric Brain Tumor Consortium |
2020-01-17 | PHASE1; PHASE2 |
| NCT04132505 | COMPLETED | Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2019-10-22 | PHASE1 |
| NCT03822780 | COMPLETED | Surfactant Dysfunction |
Children's Hospital of Fudan University |
2017-07-01 | |
| NCT05518110 | TERMINATED | Pancreatic Cancer |
Cancer Trials Ireland |
2023-05-31 | PHASE2 |
| NCT06328387 | UNKNOWN | Advanced Breast Cancer; Metastatic Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2024-01-29 | PHASE1; PHASE2 |
| NCT02735707 | RECRUITING | Community-acquired Pneumonia, Influenza, COVID-19 |
UMC Utrecht |
2016-04-11 | PHASE3 |
| NCT06479304 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-04-24 | |
| NCT06479291 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-07 | |
| NCT06479317 | RECRUITING | Immune Thrombocytopenia With Positive ANA Antibodies |
Yunfeng Cheng |
2024-04-24 | |
| NCT05083780 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer |
Changhoon Yoo |
2021-11-30 | PHASE1 |
| NCT05365893 | ACTIVE_NOT_RECRUITING | Pancreatic Ductal Adenocarcinoma |
Fox Chase Cancer Center |
2021-10-20 | EARLY_PHASE1 |
| NCT03165136 | UNKNOWN | Recurrent Miscarriage; First Trimester Abortion |
University Hospital, Brest |
2017-12-04 | PHASE3 |
| NCT05576896 | TERMINATED | Stage IV Colorectal Cancer Positive for BRAF V600E Mutation; Colorectal Cancer; Colorectal Cancer Stage IV |
Northwestern University |
2022-10-10 | PHASE2 |
| NCT05126147 | RECRUITING | Graves Ophthalmopathy |
National Taiwan University Hospital |
2022-03-21 | PHASE4 |
| NCT06776445 | COMPLETED | Rosacea; Rosacea Subtype 1 (Erythematotelangiectatic) |
First Affiliated Hospital of Chongqing Medical University |
2024-01-05 | PHASE1 |
| NCT05626348 | RECRUITING | Arthritis, Rheumatoid |
Qilu Hospital of Shandong University |
2021-12-22 | PHASE4 |
| NCT06739759 | RECRUITING | Ovarian Hyper Stimulation Syndrome (OHSS) |
Aljazeera Hospital |
2024-11-17 | |
| NCT03037437 | COMPLETED | Hepatocellular Cancer |
The University of Texas Health Science Center at San Antonio |
2017-02-16 | PHASE2 |
| NCT06939582 | RECRUITING | Radiation-induced Oral Mucositis |
Xingchen Peng |
2024-12-22 | PHASE1; PHASE2 |
| NCT04316494 | TERMINATED | ANCA Associated Vasculitis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Wegener Granulomatosis |
Guy's and St Thomas' NHS Foundation Trust |
2020-12-17 | PHASE4 |
| NCT05119140 | ACTIVE_NOT_RECRUITING | Ulcerative Colitis (Disorder) |
Icahn School of Medicine at Mount Sinai |
2022-06-10 | PHASE1; PHASE2 |
| NCT05113004 | RECRUITING | Primary Sjögren's Syndrome (pSS) |
Assistance Publique - Hôpitaux de Paris |
2022-01-20 | PHASE2 |
| NCT03008148 | UNKNOWN | Glioblastoma |
Johnpro Biotech, Inc. |
2018-10-11 | PHASE2; PHASE3 |
| NCT05689359 | WITHDRAWN | Breast Cancer; Gynecologic Cancer; Early-stage Breast Cancer; Peripheral Neuropathy; Chemotherapy-induced Peripheral Neuropathy |
University of Arizona |
2024-06 | PHASE2 |
| NCT03825289 | TERMINATED | Metastatic Pancreatic Carcinoma; Stage II Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer; Unresectable Pancreatic Carcinoma |
University of Utah |
2019-01-30 | PHASE1 |
| NCT04937907 | COMPLETED | Alport Syndrome, X-Linked |
Shanghai Children's Hospital |
2021-09-08 | PHASE2 |
| NCT05737680 | UNKNOWN | Pericarditis Idiopathic Recurrent |
Hippocration General Hospital |
2023-02 | PHASE3 |
| NCT04981145 | RECRUITING | Primary Sjögren's Syndrome |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-01-14 | PHASE4 |
| NCT04787991 | COMPLETED | Metastatic Pancreatic Adenocarcinoma |
Cancer Insight, LLC |
2021-08-09 | PHASE1 |
| NCT05942911 | TERMINATED | Rheumatoid Arthritis |
Incannex Healthcare Ltd |
2023-11-22 | PHASE2 |
| NCT04275778 | WITHDRAWN | Antiphospholipid Syndrome in Pregnancy; Anticoagulants |
Assistance Publique - Hôpitaux de Paris |
2021-07-09 | PHASE2 |
| NCT05647330 | UNKNOWN | Hydroxychloroquine; Gemcitabine; Lung Neoplasms |
Henan Cancer Hospital |
2022-12-15 | PHASE2 |
| NCT05961202 | RECRUITING | Inflammatory Cardiomyopathy; Myocarditis |
Tongji Hospital |
2021-11-01 | PHASE2; PHASE3 |
| NCT05016297 | COMPLETED | Sjogren's Syndrome |
Peking Union Medical College Hospital |
2022-07-14 | PHASE2 |
| NCT04120883 | TERMINATED | Retinitis Pigmentosa |
University of Michigan |
2020-02-25 | PHASE1; PHASE2 |
| NCT03030118 | COMPLETED | Systemic Lupus Erythematosus |
Milton S. Hershey Medical Center |
2017-12-28 | PHASE2 |
| NCT05666336 | UNKNOWN | Systemic Lupus Erythematosus |
Fen Li |
2022-12-31 | PHASE4 |
| NCT06408298 | Not yet recruiting | Resectable Localized Prostate Cancer |
Lionel.D.Lewis MD|Dartmouth Cancer Center|Dartmouth-Hitchcock Medical Center |
2024-06 | Early Phase 1 |
| NCT05221320 | TERMINATED | Tumor, Solid; Gastrointestinal Cancer |
BioMed Valley Discoveries, Inc |
2022-05-26 | PHASE2 |
| NCT05953350 | RECRUITING | Inhibition of Autophagy Synergizes Anti-tumor Effect |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2023-11-07 | PHASE1; PHASE2 |
| NCT04873895 | TERMINATED | Colorectal Neoplasms Malignant |
Abramson Cancer Center at Penn Medicine |
2022-01-24 | PHASE1 |
| NCT03774472 | COMPLETED | Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2018-08-20 | PHASE1; PHASE2 |
| NCT05841758 | Not yet recruiting | Sarcoidosis Pulmonary |
Hospices Civils de Lyon |
2024-04-01 | Phase 4 |
| NCT04011410 | COMPLETED | Prostate Cancer Recurrent |
Patrick Hensley |
2019-12-03 | PHASE2 |
| NCT04310462 | TERMINATED | Rheumatic Diseases |
University of California, San Francisco |
2017-02-01 | |
| NCT04334512 | COMPLETED | COVID-19; Corona Virus Infection; Coronavirus-19; Sars-CoV2 |
ProgenaBiome |
2020-06-22 | PHASE2 |
| NCT04669197 | COMPLETED | Untreated Resectable Pancreatic Adenocarcinoma; Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Adenocarcinoma |
HonorHealth Research Institute |
2020-12-01 | PHASE2 |
| NCT03636152 | COMPLETED | Chronic Kidney Disease; Cardiovascular Disease; Inflammation; Atherosclerosis; Aortic Stiffness |
VA Office of Research and Development |
2018-12-14 | PHASE2 |
| NCT04527549 | TERMINATED | Clinical Stage IV Cutaneous Melanoma AJCC v8; Locally Advanced Melanoma; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Unresectable Melanoma |
ECOG-ACRIN Cancer Research Group |
2021-06-01 | PHASE2 |
| NCT05084872 | UNKNOWN | Mastocytosis |
University Hospital, Toulouse |
2021-10 | PHASE2; PHASE3 |
| NCT06432101 | COMPLETED | Primary Sjögren's Syndrome |
Senyue Zhang |
2023-01-01 | |
| NCT05678335 | UNKNOWN | Sjogren Syndrome With Other Organ Involvement |
Peking Union Medical College Hospital |
2023-02 | PHASE2; PHASE3 |
| NCT03855007 | COMPLETED | Arthritis, Rheumatoid |
Qilu Hospital of Shandong University |
2016-01-01 | PHASE4 |
| NCT05013463 | UNKNOWN | Multiple Sclerosis, Secondary Progressive |
University of Calgary |
2021-10-01 | PHASE2 |
| NCT03513211 | COMPLETED | Prostate Cancer |
St Vincent's Hospital, Sydney |
2018-08-23 | PHASE1; PHASE2 |
| NCT04386057 | COMPLETED | Pancreatic Cancer; Advanced Cancer |
Kimberly Perez, MD |
2020-05-27 | PHASE2 |
| NCT04755322 | COMPLETED | Preeclampsia |
Assiut University |
2021-03-01 | |
| NCT02466581 | UNKNOWN | Rheumatoid Arthritis |
Karolinska Institutet |
2015-02-03 | PHASE4 |
| NCT00813423 | COMPLETED | Adult Solid Neoplasm |
National Cancer Institute (NCI) |
2010-02-19 | PHASE1 |
| NCT04524702 | COMPLETED | Advanced Pancreatic Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8 |
Emory University |
2020-09-14 | PHASE2 |
| NCT03025087 | TERMINATED | Individuals Undergoing Cardiac and General Surgery |
Duke University |
2017-06-19 | PHASE4 |
| NCT04372082 | WITHDRAWN | Sars-CoV2 |
University Hospital, Lille |
2020-05 | PHASE3 |
| NCT04228263 | COMPLETED | Unexplained Recurrent Miscarriage |
Assiut University |
2020-01-01 | |
| NCT04593758 | COMPLETED | Sarcoma, Clear Cell |
Cornerstone Pharmaceuticals |
2021-09-01 | PHASE1; PHASE2 |
| NCT05247554 | UNKNOWN | Pulmonary Sarcoidosis |
Assistance Publique - Hôpitaux de Paris |
2022-03-01 | PHASE3 |
| NCT03813771 | UNKNOWN | Rheumatoid Arthritis |
University of Leeds |
2019-03 | PHASE4 |
| NCT03979651 | COMPLETED | Metastatic NRAS Melanoma |
Hospices Civils de Lyon |
2019-10-15 | |
| NCT02026232 | TERMINATED | Type 2 Diabetes Mellitus |
Washington University School of Medicine |
2012-03 | |
| NCT04569890 | UNKNOWN | Rheumatoid Arthritis; Pregnancy Related |
RenJi Hospital |
2020-12-01 | |
| NCT02603146 | TERMINATED | Healthy Participants; Rheumatoid Arthritis (RA) Prevention |
National Institute of Allergy and Infectious Diseases (NIAID) |
2016-04-27 | PHASE2 |
| NCT05237843 | UNKNOWN | Recurrent Pregnancy Loss |
Ain Shams University |
2022-03-01 | PHASE1 |
| NCT04731051 | WITHDRAWN | 2019 Novel Coronavirus |
King Hussein Cancer Center |
2022-10 | PHASE1; PHASE2 |
| NCT03428945 | TERMINATED | Type1 Diabetes Mellitus |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2018-08-15 | PHASE2 |
| NCT04731051 | Withdrawn | 2019 Novel Coronavirus |
King Hussein Cancer Center|Amman Pharmaceutical Industries (API)|Sana Pharmaceutical Industry|ACDIMA Biocenter |
2022-10 | Phase 1|Phase 2 |
| NCT02842814 | COMPLETED | Systemic Lupus Erythematosus |
Peking Union Medical College Hospital |
2016-10 | |
| NCT03929211 | WITHDRAWN | Myelodysplastic Syndromes; Progressive Disease |
Wake Forest University Health Sciences |
2021-05 | PHASE1; PHASE2 |
| NCT04735068 | COMPLETED | Non-Small Cell Lung Cancer; KRAS Mutation-Related Tumors |
Abramson Cancer Center at Penn Medicine |
2021-04-09 | PHASE2 |
| NCT03540810 | UNKNOWN | Primary Antiphospholipid Syndrome |
University Hospital, Angers |
2018-08-15 | PHASE3 |
| NCT04385264 | WITHDRAWN | COVID-19 |
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland |
2022-01 | PHASE2; PHASE3 |
| NCT05113810 | UNKNOWN | 2019 Novel Coronavirus |
Ministry of Health Jordan |
2022-03-20 | PHASE2 |
| NCT04315948 | COMPLETED | Corona Virus Infection |
Institut National de la Santé Et de la Recherche Médicale, France |
2020-03-22 | PHASE3 |
| NCT03377179 | COMPLETED | Cholangiocarcinoma; Cholangiocarcinoma Non-resectable; Cholangiocarcinoma, Perihilar; Cholangiocarcinoma, Extrahepatic; Cholangiocarcinoma, Intrahepatic |
RedHill Biopharma Limited |
2018-03-07 | PHASE2 |
| NCT04145297 | COMPLETED | Gastrointestinal Neoplasms |
University of Utah |
2020-03-17 | PHASE1 |
| NCT05733897 | Recruiting | Nonalcoholic Steatohepatitis |
National Taiwan University Hospital|National Taiwan University |
2022-06-10 | -- |
| NCT04438837 | UNKNOWN | Coronavirus Disease 2019 (COVID-19); Post-Exposure Prophylaxis |
Rambam Health Care Campus |
2020-07 | |
| NCT04335084 | COMPLETED | COVID-19; Coronavirus Infection; Sars-CoV2; Corona Virus Infection; COVID; Coronavirus; Coronavirus-19; Coronavirus 19 |
ProgenaBiome |
2020-06-22 | PHASE2 |
| NCT04973566 | COMPLETED | Healthy |
Janssen Research & Development, LLC |
2021-08-31 | PHASE1 |
| NCT03032406 | ACTIVE_NOT_RECRUITING | Breast Cancer Stage IIB |
Abramson Cancer Center at Penn Medicine |
2017-01-23 | PHASE2 |
| NCT04566133 | TERMINATED | Bile Duct Cancer; Biliary Cancer; Biliary Tract Neoplasms; Cholangiocarcinoma |
National Cancer Institute (NCI) |
2022-02-15 | PHASE2 |
| NCT04573153 | TERMINATED | COVID-19 |
ScandiBio Therapeutics AB |
2020-09-21 | PHASE2; PHASE3 |
| NCT04214418 | TERMINATED | Gastrointestinal Cancer |
Columbia University |
2020-02-12 | PHASE1; PHASE2 |
| NCT04374903 | WITHDRAWN | COVID-19 Patients |
King Hussein Cancer Center |
2022-04-01 | |
| NCT04359953 | TERMINATED | COVID-19 Infection |
University Hospital, Strasbourg, France |
2020-04-25 | PHASE3 |
| NCT04341207 | UNKNOWN | Cancer & COVID 19 |
Gustave Roussy, Cancer Campus, Grand Paris |
2020-04-03 | PHASE2 |
| NCT04303507 | COMPLETED | COVID19; Coronavirus; Acute Respiratory Illnesses |
University of Oxford |
2020-04-29 | |
| NCT04390152 | TERMINATED | Acute Respiratory Distress Syndrome |
BioXcellerator |
2020-01-13 | PHASE1; PHASE2 |
| NCT01506973 | COMPLETED | Advanced Adenocarcinoma; Metastatic Adenocarcinoma |
Abramson Cancer Center at Penn Medicine |
2011-12 | PHASE1; PHASE2 |
| NCT05237843 | Unknown status | Recurrent Pregnancy Loss |
Ain Shams University |
2022-03-01 | Phase 1 |
| NCT04382625 | WITHDRAWN | SARS-CoV-2 Pneumonia; COVID-19 |
Kootenai Health |
2020-10 | PHASE4 |
| NCT03305263 | UNKNOWN | Recurrent Pregnancy Loss |
Rigshospitalet, Denmark |
2018-01-25 | PHASE3 |
| NCT04163107 | COMPLETED | Multiple Myeloma |
Norwegian University of Science and Technology |
2020-01-07 | PHASE1 |
| NCT04351724 | UNKNOWN | COVID-19 |
Medical University of Vienna |
2020-04-16 | PHASE2; PHASE3 |
| NCT03754179 | UNKNOWN | Melanoma |
Universitair Ziekenhuis Brussel |
2018-01-23 | PHASE1; PHASE2 |
| NCT05311813 | COMPLETED | COVID-19 Pandemic |
Beni-Suef University |
2021-06-01 | |
| NCT04590274 | WITHDRAWN | Covid19; SARS (Severe Acute Respiratory Syndrome) |
International Brain Research Foundation |
2020-11 | PHASE1 |
| NCT04338906 | WITHDRAWN | COVID |
Heinrich-Heine University, Duesseldorf |
2020-05 | PHASE4 |
| NCT04624269 | UNKNOWN | Antiphospholipid Syndrome; Recurrent Miscarriage |
Shanghai First Maternity and Infant Hospital |
2020-12-01 | PHASE4 |
| NCT04077957 | UNKNOWN | Ankylosing Spondylitis; Spondyloarthritis |
Nanfang Hospital, Southern Medical University |
2019-10-07 | PHASE4 |
| NCT04342169 | COMPLETED | Coronavirus Infection; Coronavirus; Infectious Disease |
University of Utah |
2020-04-04 | PHASE2 |
| NCT02257424 | COMPLETED | Advanced BRAF Mutant Melanoma |
Abramson Cancer Center at Penn Medicine |
2014-10 | PHASE1; PHASE2 |
| NCT04954040 | UNKNOWN | Acute Respiratory Distress Syndrome; Covid19 |
Maimónides Biomedical Research Institute of Córdoba |
2021-02-10 | PHASE2 |
| NCT04395768 | UNKNOWN | COVID19 |
National Institute of Integrative Medicine, Australia |
2020-09-09 | PHASE2 |
| NCT04363827 | TERMINATED | COVID19; Hydroxychloroquine; Prophylaxis; Treatment; SARS-CoV-2 |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
2020-05-14 | PHASE2 |
| NCT04380818 | UNKNOWN | Pneumonia, Viral |
Grupo de Investigación Clínica en Oncología Radioterapia |
2020-06-05 | |
| NCT03671174 | UNKNOWN | Undifferentiated Connective Tissue Disease; Recurrent Pregnancy Loss |
RenJi Hospital |
2019-08-02 | |
| NCT04437693 | UNKNOWN | COVID 19 |
Hamad Medical Corporation |
2020-08-31 | PHASE2; PHASE3 |
| NCT04303299 | COMPLETED | SARS-COV-2 Infections; COVID-19 |
Department of Medical Services Ministry of Public Health of Thailand |
2020-08-19 | PHASE3 |
| NCT05026801 | WITHDRAWN | Respiratory Tract Infection Viral |
Iterum Therapeutics, International Limited |
2021-02-08 | PHASE3 |
| NCT04964583 | UNKNOWN | Covid19 |
Coordinación de Investigación en Salud, Mexico |
2021-01-20 | PHASE2; PHASE3 |
| NCT04389359 | WITHDRAWN | COVID-19 |
Cambridge University Hospitals NHS Foundation Trust |
2020-09 | PHASE2; PHASE3 |
| NCT04466540 | COMPLETED | COVID-19 |
Hospital Alemão Oswaldo Cruz |
2020-05-12 | PHASE4 |
| NCT01573754 | COMPLETED | Porphyria Cutanea Tarda |
The University of Texas Medical Branch, Galveston |
2006-03-21 | PHASE2 |
| NCT04459702 | WITHDRAWN | COVID; COVID-19; Corona Virus Infection; Coronavirus Infection; Coronavirus Sars-Associated as Cause of Disease Classified Elsewhere; Coronavirus-19; SARS-CoV 2; SARS Pneumonia |
ProgenaBiome |
2020-07 | PHASE2 |
| NCT04858633 | UNKNOWN | Covid19; COVID-19 Prevention |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2021-03-22 | PHASE3 |
| NCT04410562 | COMPLETED | Pregnancy Related; COVID; Covid-19 |
Barcelona Institute for Global Health |
2020-05-13 | PHASE3 |
| NCT04372017 | TERMINATED | COVID-19; SARS-CoV 2 |
Sanford Health |
2020-05-14 | PHASE3 |
| NCT04332094 | UNKNOWN | COVID-19 |
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
2020-04-02 | PHASE2 |
| NCT04371926 | WITHDRAWN | COVID-19 |
Texas Cardiac Arrhythmia Research Foundation |
2020-06 | |
| NCT04435587 | UNKNOWN | Asymptomatic Infections; SARS-CoV2 Infection |
Mahidol University |
2020-07-13 | PHASE4 |
| NCT02913157 | COMPLETED | Multiple Sclerosis, Primary Progressive |
University of Calgary |
2016-11 | PHASE2 |
| NCT04340349 | UNKNOWN | Hydroxychloroquine; Antimalarials; Enzyme Inhibitors; Antirheumatic Agents |
Instituto Nacional de Rehabilitacion |
2021-02-01 | EARLY_PHASE1 |
| NCT04715295 | UNKNOWN | COVID-19 |
Yaounde Central Hospital |
2020-10-05 | PHASE4 |
| NCT04360759 | WITHDRAWN | Covid-19; HIV |
University of Cape Town |
2020-05-01 | PHASE3 |
| NCT04334967 | SUSPENDED | COVID-19; Corona Virus Infection; SARS-CoV-2; 2019-nCoV; 2019 Novel Coronavirus |
Providence Health & Services |
2020-03-30 | PHASE4 |
| NCT04373044 | TERMINATED | Symptomatic COVID-19 Infection Laboratory-Confirmed |
University of Southern California |
2020-05-01 | PHASE2 |
| NCT02374021 | COMPLETED | Arthritis, Rheumatoid |
Brigham and Women's Hospital |
2016-07 | PHASE4 |
| NCT04364815 | WITHDRAWN | COVID-19 |
University of the Philippines |
2020-12 | PHASE3 |
| NCT04397328 | WITHDRAWN | COVID-19 |
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
2020-05-30 | PHASE3 |
| NCT04381988 | TERMINATED | COVID-19; Cancer |
Memorial Sloan Kettering Cancer Center |
2020-05-07 | PHASE2 |
| NCT05024006 | COMPLETED | Covid19 |
University of the Philippines |
2020-04-23 | |
| NCT04344444 | TERMINATED | COVID-19 |
LCMC Health |
2020-04-13 | PHASE3 |
| NCT04369742 | TERMINATED | COVID-19 |
NYU Langone Health |
2020-04-15 | PHASE2 |
| NCT04341727 | TERMINATED | Coronavirus Infection |
Washington University School of Medicine |
2020-04-04 | PHASE3 |
| NCT04363450 | UNKNOWN | COVID-19; Corona Virus Infection; Wuhan Coronavirus; Prophylaxis; Healthcare Worker; Sars-CoV2; Hydroxychloroquine |
Louisiana State University Health Sciences Center in New Orleans |
2020-04-27 | PHASE3 |
| NCT04318444 | TERMINATED | COVID-19; Corona Virus Infection |
Columbia University |
2020-03-29 | PHASE2; PHASE3 |
| NCT04374942 | TERMINATED | Pre-Exposure Prophylaxis; Coronavirus; SARS-CoV 2 |
Megan Landes |
2020-04-30 | PHASE3 |
| NCT04712279 | UNKNOWN | Covid19 |
Corpometria Institute |
2021-01-25 | PHASE2; PHASE3 |
| NCT02722369 | TERMINATED | Small Cell Lung Cancer |
University College, London |
2017-03-14 | PHASE2 |
| NCT04779047 | UNKNOWN | Covid19; Pneumonia |
October 6 University |
2020-10-01 | PHASE4 |
| NCT04387760 | COMPLETED | SARS-CoV 2; COVID-19 |
Royal College of Surgeons in Ireland - Medical University of Bahrain |
2020-08-11 | PHASE2 |
| NCT04363866 | WITHDRAWN | COVID-19; SARS-CoV-2 |
Oregon Health and Science University |
2020-08 | PHASE2 |
| NCT04363203 | SUSPENDED | SARS-CoV-2; COVID-19 |
Salomeh Keyhani MD |
2020-04-30 | PHASE3 |
| NCT04342221 | TERMINATED | COVID-19, Hydroxychloroquine Sulfate |
University Hospital Tuebingen |
2020-03-29 | PHASE3 |
| NCT04334928 | COMPLETED | Coronavirus Infection |
Plan Nacional sobre el Sida (PNS) |
2020-04-15 | PHASE3 |
| NCT01266057 | COMPLETED | Advanced Cancers |
M.D. Anderson Cancer Center |
2011-04-28 | PHASE1 |
| NCT04860284 | UNKNOWN | Covid19 |
Makerere University |
2020-09-18 | PHASE2 |
| NCT04345861 | TERMINATED | Coronavirus Infection; Pneumonia, Viral |
University Hospital, Montpellier |
2020-04-11 | PHASE2; PHASE3 |
| NCT04322396 | TERMINATED | Virus Diseases; Infection Viral; Corona Virus Infection |
Chronic Obstructive Pulmonary Disease Trial Network, Denmark |
2020-04-06 | PHASE2 |
| NCT04403100 | UNKNOWN | COVID-19; Coronavirus Infection; Virus Disease; Acute Respiratory Infection; SARS-CoV Infection |
Cardresearch |
2020-06-03 | PHASE3 |
| NCT04981379 | COMPLETED | Covid19 |
Health Institutes of Turkey |
2020-11-16 | PHASE3 |
| NCT04746365 | COMPLETED | Covid19 |
Elaraby Hospital |
2020-12-06 | PHASE4 |
| NCT04392973 | COMPLETED | COVID19 |
King Abdullah International Medical Research Center |
2020-05-21 | |
| NCT04605588 | TERMINATED | SARS-CoV Infection; Covid19 |
Rutgers, The State University of New Jersey |
2020-12-02 | PHASE2 |
| NCT04597775 | UNKNOWN | SARS-CoV Infection |
Regional Center for Disease Control and Prevention, Jordan |
2020-10-27 | PHASE2; PHASE3 |
| NCT04334382 | UNKNOWN | COVID-19 |
Intermountain Health Care, Inc. |
2020-04-02 | PHASE3 |
| NCT04365582 | WITHDRAWN | COVID |
Fondation Hôpital Saint-Joseph |
2020-05-07 | PHASE3 |
| NCT04394182 | SUSPENDED | Pneumonia, Viral; Cytokine Storm |
Fundacion GenesisCare |
2020-04-21 | |
| NCT04351516 | WITHDRAWN | SARS-CoV 2; COVID-19 |
University Hospital Tuebingen |
2020-04-21 | PHASE2; PHASE3 |
| NCT04318015 | COMPLETED | COVID-19; Severe Acute Respiratory Syndrome |
National Institute of Respiratory Diseases, Mexico |
2020-04-14 | PHASE3 |
| NCT04411433 | UNKNOWN | Sars-CoV2; COVID-19 |
Ministry of Health, Turkey |
2020-05-08 | PHASE3 |
| NCT03122431 | COMPLETED | Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus |
University of Sao Paulo General Hospital |
2017-06-05 | PHASE4 |
| NCT04347889 | WITHDRAWN | Covid-19 |
Stony Brook University |
2020-04-20 | PHASE2 |
| NCT03400865 | UNKNOWN | Resistance, Disease; Prolactinoma |
Zhebao Wu |
2018-10-25 | |
| NCT04400019 | UNKNOWN | Sars-CoV2; Coronavirus Infection; Prevention & Control; Nursing Home; Hydroxychloroquine |
University of Malaga |
2020-09 | PHASE2; PHASE3 |
| NCT04341441 | TERMINATED | COVID-19; Coronavirus; Coronavirus Infections; SARS-CoV 2 |
Henry Ford Health System |
2020-04-07 | PHASE3 |
| NCT04334148 | COMPLETED | COVID-19 |
Adrian Hernandez |
2020-04-22 | PHASE3 |
| NCT04429867 | UNKNOWN | COVID-19 |
WellStar Health System |
2020-05-07 | PHASE4 |
| NCT04405921 | UNKNOWN | SARS-CoV-2 Pneumonia; COVID-19 |
Centre Hôpital Universitaire Farhat Hached |
2020-07 | PHASE3 |
| NCT04414241 | COMPLETED | SARS-CoV-2 |
Universidad Peruana Cayetano Heredia |
2020-06-25 | PHASE3 |
| NCT04338698 | COMPLETED | COVID 19 |
Shehnoor Azhar |
2020-04-22 | PHASE3 |
| NCT04788355 | COMPLETED | Complication |
Universidade do Vale do Sapucai |
2020-07-01 | PHASE3 |
| NCT04329923 | TERMINATED | COVID-19 |
Ravi Amaravadi, MD |
2020-04-09 | PHASE2 |
| NCT04391127 | COMPLETED | COVID-19 |
Centenario Hospital Miguel Hidalgo |
2020-05-04 | PHASE3 |
| NCT04330495 | WITHDRAWN | COVID 19; Immunomediated Inflammatory Disease in Treatment With Biological Agents and / or Jak Inhibitors |
Instituto de Investigación Marqués de Valdecilla |
2020-04-06 | PHASE4 |
| NCT04339816 | TERMINATED | COVID-19; Respiratory Failure |
Frantisek Duska, MD, PhD |
2020-05-13 | PHASE3 |
| NCT04361461 | WITHDRAWN | Coronavirus Infections; SARS-CoV 2; SARS (Severe Acute Respiratory Syndrome); Pulmonary Disease |
Apsen Farmaceutica S.A. |
2020-04-30 | PHASE3 |
| NCT04354428 | TERMINATED | COVID-19; SARS-CoV-2 |
University of Washington |
2020-04-16 | PHASE2; PHASE3 |
| NCT04347031 | COMPLETED | Pneumonia, Viral; Respiratory Failure |
Burnasyan Federal Medical Biophysical Center |
2020-04-08 | PHASE2; PHASE3 |
| NCT04374552 | WITHDRAWN | SARS-CoV-2 Infection |
Rutgers, The State University of New Jersey |
2020-05-05 | PHASE2 |
| NCT04652648 | COMPLETED | Covid19; Hydroxychloroquine; Coronavirus Infection; Transmission; Prophylaxis |
Bryn Mawr Hospital |
2020-05-27 | PHASE4 |
| NCT04352933 | UNKNOWN | COVID-19 |
Cambridge University Hospitals NHS Foundation Trust |
2020-05-11 | PHASE3 |
| NCT04366089 | UNKNOWN | COVID; SARS-CoV 2; Pneumonia, Viral; Coronavirus Infection |
Roberto Poscia MD, PhD |
2020-03-26 | PHASE2 |
| NCT04497519 | COMPLETED | Covid19 |
University Medical Center Groningen |
2020-09-15 | PHASE1 |
| NCT04336332 | TERMINATED | SARS-CoV-2; COVID-19 |
Rutgers, The State University of New Jersey |
2020-04-01 | PHASE2 |
| NCT04340544 | TERMINATED | COVID-19 |
University Hospital Tuebingen |
2020-04-22 | PHASE2 |
| NCT04355052 | UNKNOWN | COVID - 19 |
Sheba Medical Center |
2020-04-11 | PHASE3 |
| NCT04005781 | UNKNOWN | Obesity |
Universitaire Ziekenhuizen KU Leuven |
2019-10-01 | PHASE4 |
| NCT04361318 | UNKNOWN | COVID-19 |
Tanta University |
2020-05 | PHASE2; PHASE3 |
| NCT04443725 | UNKNOWN | COVID-19 |
Cairo University |
2020-07 | PHASE2; PHASE3 |
| NCT04370782 | COMPLETED | COVID-19 |
St. Francis Hospital, New York |
2020-04-28 | PHASE4 |
| NCT04379492 | WITHDRAWN | COVID-19; COVID19; Sars-CoV2; SARS-Cov-2 |
Memorial Sloan Kettering Cancer Center |
2020-05-05 | PHASE2 |
| NCT04328961 | COMPLETED | COVID-19; Corona Virus Infection; SARS (Severe Acute Respiratory Syndrome); SARS-CoV-2 |
University of Washington |
2020-03-31 | PHASE2; PHASE3 |
| NCT04466280 | WITHDRAWN | COVID-19 |
Baqiyatallah Medical Sciences University |
2020-08-12 | |
| NCT04668469 | COMPLETED | Covid19 |
Benha University |
2020-06-08 | |
| NCT04354870 | COMPLETED | COVID-19 |
NYU Langone Health |
2020-04-03 | PHASE2 |
| NCT04349410 | COMPLETED | CoVid 19 Positive |
The Camelot Foundation |
2020-04-11 | PHASE2; PHASE3 |
| NCT04384458 | UNKNOWN | Coronavirus Infections |
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara |
2020-07-20 | |
| NCT04392128 | WITHDRAWN | COVID19; Hematologic Malignancy |
Institut de cancérologie Strasbourg Europe |
2020-09-02 | PHASE2 |
| NCT04575558 | WITHDRAWN | Sars-CoV2 |
Latin American Cooperative Oncology Group |
2020-06-30 | PHASE2 |
| NCT04390061 | UNKNOWN | Pneumonitis, Interstitial; COVID-19 |
Università Politecnica delle Marche |
2020-06 | PHASE2 |
| NCT04345692 | TERMINATED | COVID-19 |
Queen's Medical Center |
2020-03-26 | PHASE3 |
| NCT04446104 | COMPLETED | Covid-19 |
National University Hospital, Singapore |
2020-05-13 | PHASE3 |
| NCT04383717 | UNKNOWN | Respiratory Tract Infections |
Cairo University |
2020-05-05 | PHASE3 |
| NCT04501965 | UNKNOWN | Covid19 |
Institute for Research and Development of Medicinal and Food Plants of Guinea |
2020-06-01 | PHASE2 |
| NCT04341493 | TERMINATED | Coronavirus Infection |
Hugo Mendieta Zeron |
2020-04-06 | PHASE4 |
| NCT04502342 | UNKNOWN | Covid19 |
Institute for Research and Development of Medicinal and Food Plants of Guinea |
2020-06-01 | PHASE2 |
| NCT04458948 | TERMINATED | COVID-19 |
University of New Mexico |
2020-03-24 | PHASE2 |
| NCT04359537 | UNKNOWN | COVID 19 |
Shaheed Zulfiqar Ali Bhutto Medical University |
2020-05-01 | PHASE2 |
| NCT04351191 | TERMINATED | Sars-CoV2; Symptomatic Condition; Covid-19 |
Government of Punjab, Specialized Healthcare and Medical Education Department |
2020-04-15 | PHASE4 |
| NCT04346667 | TERMINATED | SARS-CoV-2; Coronavirus Infection; Asymptomatic Condition; COVID-19 |
Government of Punjab, Specialized Healthcare and Medical Education Department |
2020-04-14 | PHASE4 |
| NCT04420247 | COMPLETED | COVID; COVID-19; SARS-CoV 2; Coronavirus; Corona Virus Infection |
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva |
2020-04-16 | PHASE3 |
| NCT04421664 | TERMINATED | Corona Virus Infection; SARS-CoV Infection; Coronavirus |
McGill University Health Centre/Research Institute of the McGill University Health Centre |
2020-03-25 | PHASE3 |
| NCT04461353 | COMPLETED | Severe Acute Respiratory Syndrome Coronavirus 2 |
Pulmoquine Therapeutics, Inc |
2020-06-25 | PHASE1 |
| NCT04477083 | UNKNOWN | Covid19; Hydroxychloroquine Adverse Reaction |
Mansoura University |
2020-07-15 | |
| NCT04354597 | WITHDRAWN | COVID-19 |
King Hussein Cancer Center |
2020-05-01 | |
| NCT04349592 | COMPLETED | Covid19 |
Hamad Medical Corporation |
2020-04-14 | |
| NCT04347980 | TERMINATED | Respiratory Distress Syndrome, Adult; COVID-19 |
Centre Chirurgical Marie Lannelongue |
2020-04-17 | PHASE3 |
| NCT02595346 | TERMINATED | Antiphospholipid Syndrome (APS) |
University Hospital, Rouen |
2016-05-17 | PHASE2 |
| NCT04394442 | UNKNOWN | COVID-19 |
Samah Lutfy |
2020-03-21 | PHASE2 |
| NCT04321616 | UNKNOWN | SARS-CoV Infection; COVID 19; Acute Respiratory Distress Syndrome ARDS |
Oslo University Hospital |
2020-03-28 | PHASE2; PHASE3 |
| NCT04350450 | WITHDRAWN | COVID; Coronavirus; COVID-19 |
Montefiore Medical Center |
2020-04 | PHASE2 |
| NCT04342156 | WITHDRAWN | Coronavirus Infection; Hydroxychloroquine Adverse Reaction |
Tan Tock Seng Hospital |
2020-04 | PHASE3 |
| NCT04371406 | WITHDRAWN | Covid-19 |
Assistance Publique - Hôpitaux de Paris |
2020-04 | PHASE3 |
| NCT04371523 | WITHDRAWN | Corona Virus Infection |
St. Joseph's Healthcare Hamilton |
2020-05-01 | PHASE3 |
| NCT05110651 | WITHDRAWN | COVID-19; End Stage Renal Disease |
Nicholas Carlson |
2020-04-10 | PHASE4 |
| NCT04408456 | COMPLETED | CoVID-19 |
Post Graduate Institute of Medical Education and Research, Chandigarh |
2020-03-01 | PHASE3 |
| NCT04358081 | COMPLETED | Covid-19 |
Novartis Pharmaceuticals |
2020-05-01 | PHASE3 |
| NCT04329611 | TERMINATED | COVID-19 |
Dr. Michael Hill |
2020-04-13 | PHASE3 |
| NCT01379573 | COMPLETED | Congenital Heart Block; Neonatal Lupus; Autoantibody-Associated Heart Block |
NYU Langone Health |
2011-01-01 | PHASE2 |
| NCT04351919 | WITHDRAWN | Patients With COVID19 |
Abderrahmane Mami Hospital |
2020-05-05 | PHASE4 |
| NCT04528927 | WITHDRAWN | COVID 19; Patients Hospitalized |
Abderrahmane Mami Hospital |
2020-05-15 | PHASE3 |
| NCT04447534 | COMPLETED | COVID |
Tanta University |
2020-06-23 | PHASE3 |
| NCT04435808 | TERMINATED | COVID-19 |
University of New Mexico |
2020-04-14 | PHASE1; PHASE2 |
| NCT04349228 | WITHDRAWN | COVID19; Sars-CoV2; Hydroxychloroquine; Prophylaxis; Healthcare Worker |
Abderrahmane Mami Hospital |
2020-04-28 | PHASE3 |
| NCT04328467 | COMPLETED | COVID-19; Corona Virus Infection; ARDS; Acute Respiratory Distress Syndrome |
University of Minnesota |
2020-04-06 | PHASE3 |
| NCT04353037 | TERMINATED | Coronavirus; Corona Virus Infection |
UnitedHealth Group |
2020-04-07 | PHASE2 |
| NCT04358068 | TERMINATED | COVID-19; SARS-CoV 2 |
National Institute of Allergy and Infectious Diseases (NIAID) |
2020-05-13 | PHASE2 |
| NCT04353271 | TERMINATED | Covid 19; Corona Virus Infection |
University of South Alabama |
2020-04-17 | PHASE2; PHASE3 |
| NCT04315896 | COMPLETED | COVID-19; Severe Acute Respiratory Syndrome |
National Institute of Respiratory Diseases, Mexico |
2020-04-14 | PHASE3 |
| NCT04329832 | COMPLETED | COVID-19 |
Intermountain Health Care, Inc. |
2020-03-30 | PHASE2 |
| NCT04350281 | COMPLETED | COVID |
The University of Hong Kong |
2020-04-09 | PHASE2 |
| NCT04336748 | WITHDRAWN | Sars-CoV2; Infection Viral; Healthcare Worker; Prophylaxis |
Medical University of Vienna |
2020-04 | PHASE3 |
| NCT04348474 | SUSPENDED | Covid-19 |
Azidus Brasil |
2020-04-20 | EARLY_PHASE1 |
| NCT04161339 | UNKNOWN | Cardiovascular Diseases; Endothelial Dysfunction; Sleep Apnea; Atherosclerosis; Coronary Artery Disease |
Instituto de Cardiologia do Rio Grande do Sul |
2019-07-01 | PHASE4 |
| NCT04333225 | COMPLETED | COVID-19 |
Baylor Research Institute |
2020-04-03 | PHASE2 |
| NCT04355026 | UNKNOWN | Covid-19 |
General and Teaching Hospital Celje |
2020-04-10 | PHASE4 |
| NCT04370015 | UNKNOWN | SARS-CoV-2; Healthcare Workers |
Services Institute of Medical Sciences, Pakistan |
2020-05-15 | |
| NCT04346329 | WITHDRAWN | COVID |
Universidad Nacional de Colombia |
2020-03-30 | PHASE3 |
| NCT04330144 | WITHDRAWN | Contact Person From COVID-19 Confirmed Patient |
Gangnam Severance Hospital |
2020-04-01 | PHASE3 |
| NCT04331834 | COMPLETED | COVID-19 |
Barcelona Institute for Global Health |
2020-04-03 | PHASE3 |
| NCT04352946 | UNKNOWN | Prophylaxis; COVID-19; Health Care Worker; Hydroxychloroquine |
GeoSentinel Foundation |
2020-04-24 | PHASE3 |
| NCT04344457 | UNKNOWN | COVID-19 |
Perseverance Research Center, LLC |
2020-04-16 | PHASE1; PHASE2 |
| NCT04332991 | COMPLETED | Coronavirus; Acute Respiratory Infection; SARS-CoV Infection |
Massachusetts General Hospital |
2020-04-02 | PHASE3 |
| NCT04325893 | TERMINATED | Coronavirus |
University Hospital, Angers |
2020-04-01 | PHASE3 |
| NCT04344379 | COMPLETED | SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-17 | PHASE3 |
| NCT04335552 | TERMINATED | SARS-CoV-2 |
Duke University |
2020-04-17 | PHASE2 |
| NCT04321278 | COMPLETED | Coronavirus Infections; Pneumonia, Viral |
Hospital Israelita Albert Einstein |
2020-03-28 | PHASE3 |
| NCT04351620 | COMPLETED | COVID-19 |
University of Chicago |
2020-04-20 | PHASE1 |
| NCT04362332 | TERMINATED | COVID-19 |
UMC Utrecht |
2020-04-14 | PHASE4 |
| NCT04345653 | COMPLETED | Covid19 |
Hackensack Meridian Health |
2020-04-14 | PHASE2 |
| NCT04423991 | COMPLETED | COVID-19; Coronavirus; Mortality |
Dascena |
2020-03-10 | |
| NCT04322123 | COMPLETED | Coronavirus Infections |
Hospital do Coracao |
2020-04-01 | PHASE3 |
| NCT04347512 | WITHDRAWN | Sars-CoV-2, Community-Acquired Pneumonia,COVID-19 |
University Hospital, Strasbourg, France |
2020-06-02 | PHASE3 |
| NCT04353336 | COMPLETED | COVID-19; Coronavirus Infection |
Tanta University |
2020-03-23 | PHASE2; PHASE3 |
| NCT03215264 | COMPLETED | Colorectal Cancer |
Abramson Cancer Center at Penn Medicine |
2017-10-02 | PHASE1 |
| NCT04365231 | WITHDRAWN | COVID19 |
Hospital St. Joseph, Marseille, France |
2020-04-01 | PHASE3 |
| NCT04329572 | SUSPENDED | COVID-19 |
Azidus Brasil |
2020-04-23 | EARLY_PHASE1 |
| NCT04384380 | COMPLETED | Coronavirus Infection |
Taoyuan General Hospital |
2020-04-01 | |
| NCT04491994 | COMPLETED | Covid19; Progression |
UNICEF |
2020-04-10 | PHASE3 |
| NCT03283566 | COMPLETED | Chronic Pancreatitis; Insulin Dependent Diabetes |
The Cleveland Clinic |
2017-10-03 | PHASE2 |
| NCT04328272 | UNKNOWN | COVID19 |
Prof. Dr. Umar Farooq |
2020-03-28 | PHASE3 |
| NCT04522466 | TERMINATED | Sars-CoV2 |
Centre Hospitalier Universitaire de Saint Etienne |
2020-04-03 | PHASE3 |
| NCT04333654 | TERMINATED | Coronavirus Infection |
Sanofi |
2020-04-12 | PHASE1 |
| NCT04316377 | UNKNOWN | Corona Virus Infection |
University Hospital, Akershus |
2020-03-25 | PHASE4 |
| NCT04377646 | UNKNOWN | Sars-CoV2; COVID19 |
Military Hospital of Tunis |
2020-05-04 | PHASE3 |
| NCT04308668 | COMPLETED | Corona Virus Infection; Acute Respiratory Distress Syndrome; SARS-CoV Infection; Coronavirus; Coronavirus Infections |
University of Minnesota |
2020-03-17 | PHASE3 |
| NCT04328285 | TERMINATED | COVID-19 |
Centre Hospitalier Universitaire de Saint Etienne |
2020-04-14 | PHASE3 |
| NCT04341870 | SUSPENDED | COVID19; SARS-CoV-2 Infection |
Assistance Publique - Hôpitaux de Paris |
2020-04-11 | PHASE2; PHASE3 |
| NCT03856866 | COMPLETED | Zellweger Syndrome; Peroxisome Biogenesis Disorders |
The Hospital for Sick Children |
2019-01-11 | PHASE2 |
| NCT04359316 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-20 | PHASE4 |
| NCT04359615 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-20 | PHASE4 |
| NCT04354441 | WITHDRAWN | COVID-19; SARS-CoV-2; Pregnant Women; Hydroxychloroquine |
Sir Mortimer B. Davis - Jewish General Hospital |
2020-05 | PHASE2 |
| NCT04307693 | TERMINATED | COVID-19 |
Asan Medical Center |
2020-03-11 | PHASE2 |
| NCT04323631 | WITHDRAWN | COVID-19 |
Rambam Health Care Campus |
2020-04-30 | EARLY_PHASE1 |
| NCT04343768 | COMPLETED | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-09 | PHASE2 |
| NCT04350684 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-15 | PHASE4 |
| NCT04350671 | UNKNOWN | COVID-19 |
Shahid Beheshti University of Medical Sciences |
2020-04-15 | PHASE4 |
| NCT04376814 | COMPLETED | COVID-19; Favipiravir; Kaletra; Hydroxychloroquine; Lopinavir/Ritonavir |
Baqiyatallah Medical Sciences University |
2020-03-29 | |
| NCT04261517 | COMPLETED | Pneumonia, Pneumocystis; Coronavirus; COVID-19 |
Shanghai Public Health Clinical Center |
2020-02-06 | PHASE3 |
| NCT01480154 | ACTIVE_NOT_RECRUITING | Advanced Malignant Solid Neoplasm; Stage III Cutaneous Melanoma AJCC v7; Stage III Prostate Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Stage IV Prostate Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7 |
National Cancer Institute (NCI) |
2011-11-23 | PHASE1 |
| NCT03015324 | COMPLETED | Solid Tumor |
Peng Wang, MD PhD |
2017-08-08 | PHASE1 |
| NCT02648464 | COMPLETED | Myocardial Infarction; Acute Coronary Syndrome; Inflammation; Hydroxychloroquine; Antirheumatic Agents; Cardiovascular Diseases |
Helsinki University Central Hospital |
2016-02-01 | PHASE4 |
| NCT03592823 | UNKNOWN | Atrial Fibrillation |
First Affiliated Hospital of Harbin Medical University |
2018-08-01 | PHASE4 |
| NCT04005768 | UNKNOWN | Obesity |
Universitaire Ziekenhuizen KU Leuven |
2019-08-01 | PHASE4 |
| NCT04153201 | COMPLETED | Antiphospholipid Syndrome |
National and Kapodistrian University of Athens |
2013-01-15 | |
| NCT03400254 | WITHDRAWN | Breast Cancer |
Abramson Cancer Center at Penn Medicine |
2019-02-26 | PHASE1; PHASE2 |
| NCT03081702 | COMPLETED | Platinum-resistant Epithelial Ovarian Cancer |
University Health Network, Toronto |
2017-07-25 | PHASE1; PHASE2 |
| NCT04022421 | UNKNOWN | Behcet's Syndrome, Vascular Type |
Assiut University |
2018-10-01 | |
| NCT03449758 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2018-03-05 | PHASE4 |
| NCT01946880 | TERMINATED | Systemic Lupus Erythematosus; SLE |
National Institute of Allergy and Infectious Diseases (NIAID) |
2013-11-20 | PHASE2 |
| NCT02379650 | WITHDRAWN | Recurrent Pregnancy Loss; Miscarriage |
University of Utah |
2016-07 | PHASE2 |
| NCT03275870 | COMPLETED | Hidradenitis Suppurativa; Hidradenitis; Acne Inversa; Boils; Follicular Occlusion Triad; Follicular Occlusion Tetrad |
Elena Gonzalez Brant, MD |
2017-09-28 | PHASE1; PHASE2 |
| NCT02615938 | TERMINATED | Interstitial Lung Disease; Diffuse Parenchymal Lung Disease; Children´s Interstitial Lung Disease |
Matthias Griese |
2015-08-21 | PHASE2 |
| NCT02765594 | UNKNOWN | Primary IgA Nephropathy |
Peking Union Medical College Hospital |
2016-06 | PHASE4 |
| NCT03344172 | TERMINATED | Pancreatic Cancer Resectable |
Nathan Bahary, MD |
2017-12-13 | PHASE2 |
| NCT01783106 | COMPLETED | Crohn's Disease |
Royal Liverpool University Hospital |
2014-02-01 | PHASE2 |
| NCT02874287 | COMPLETED | Coronary Artery Disease |
First Affiliated Hospital Xi'an Jiaotong University |
2017-10-08 | PHASE4 |
| NCT02444728 | TERMINATED | Thrombocytopenia |
Chinese SLE Treatment And Research Group |
2015-07 | PHASE3 |
| NCT02013778 | TERMINATED | Hepatocellular Carcinoma |
Abramson Cancer Center at Penn Medicine |
2013-11 | PHASE1; PHASE2 |
| NCT01494155 | COMPLETED | Pancreatic Cancer |
Massachusetts General Hospital |
2011-12-27 | PHASE2 |
| NCT02930343 | TERMINATED | Rheumatoid Arthritis |
Jawaharlal Institute of Postgraduate Medical Education & Research |
2016-09 | PHASE3 |
| NCT02910076 | UNKNOWN | Diabetes Type Two |
Hadassah Medical Organization |
2016-10 | PHASE1; PHASE2 |
| NCT03229746 | COMPLETED | Immune Thrombocytopenia |
Assiut University |
2017-08-01 | PHASE4 |
| NCT02316340 | COMPLETED | Colorectal Cancer |
The University of Texas Health Science Center at San Antonio |
2015-02-11 | PHASE2 |
| NCT01550367 | COMPLETED | Metastatic Renal Cell Carcinoma |
Leonard Appleman |
2012-03 | PHASE1; PHASE2 |
| NCT01978184 | COMPLETED | Pancreatic Cancer |
Nathan Bahary, MD |
2013-11 | PHASE2 |
| NCT02942381 | COMPLETED | IgA Patients; Hydroxychloroquine |
Peking University First Hospital |
2016-09-13 | PHASE2 |
| NCT02232243 | COMPLETED | Solid Tumor |
Peng Wang, MD PhD |
2015-07 | PHASE1 |
| NCT02470468 | COMPLETED | Stage IV Non-small Cell Lung Cancer |
SOTIO a.s. |
2014-12 | PHASE1; PHASE2 |
| NCT01023737 | COMPLETED | Malignant Solid Tumour |
The University of Texas Health Science Center at San Antonio |
2009-11 | PHASE1 |
| NCT02303405 | TERMINATED | Diabetes Mellitus Type 2 With Hyperglycemia |
Charles Drew University of Medicine and Science |
2014-11 | PHASE2 |
| NCT03085940 | COMPLETED | Rheumatoid Arthritis |
Indonesia University |
2017-01-20 | |
| NCT01206530 | COMPLETED | Rectal Cancer; Colon Cancer; Metastasis; Adenocarcinoma |
Abramson Cancer Center at Penn Medicine |
2010-09 | PHASE1; PHASE2 |
| NCT02451748 | COMPLETED | Rheumatoid Arthritis |
University of Illinois at Chicago |
2015-08 | PHASE4 |
| NCT02433184 | COMPLETED | Rheumatoid Arthritis |
University of Leeds |
2011-07 | PHASE4 |
| NCT02551575 | UNKNOWN | Rheumatoid Arthritis |
Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
2014-11 | PHASE2; PHASE3 |
| NCT02644499 | COMPLETED | Rheumatoid Arthritis |
Jawaharlal Institute of Postgraduate Medical Education & Research |
2015-12-31 | PHASE4 |
| NCT02320630 | UNKNOWN | Recurrence (Disease Attribute) |
Peking University First Hospital |
2015-10 | |
| NCT01602588 | COMPLETED | Glioblastoma |
University College, London |
2013-05 | PHASE2 |
| NCT02631252 | TERMINATED | Leukemia, Acute Myelogenous |
Alison Sehgal, MD, MS |
2016-08-18 | PHASE1 |
| NCT01144169 | TERMINATED | Renal Cell Carcinoma |
University of Pittsburgh |
2010-10 | PHASE1 |
| NCT02124681 | COMPLETED | Insulin Resistance |
University of Pittsburgh |
2014-04 | PHASE1 |
| NCT01897116 | COMPLETED | Melanoma |
Abramson Cancer Center at Penn Medicine |
2013-06 | PHASE1 |
| NCT01941095 | COMPLETED | Rheumatoid Arthritis |
Hoffmann-La Roche |
2013-11-20 | PHASE3 |
| NCT01510119 | COMPLETED | Metastatic Clear Cell Renal Cell Carcinoma |
Abramson Cancer Center at Penn Medicine |
2011-09 | PHASE1; PHASE2 |
| NCT01689987 | COMPLETED | Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
OHSU Knight Cancer Institute |
2012-09 | PHASE1 |
| NCT01645176 | COMPLETED | Osteoarthritis of the Knee |
Stanford University |
2012-05 | PHASE2 |
| NCT02421575 | TERMINATED | Prostate Carcinoma |
Rutgers, The State University of New Jersey |
2012-07 | EARLY_PHASE1 |
| NCT01828476 | TERMINATED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2013-06 | PHASE2 |
| NCT02126683 | UNKNOWN | Hashimoto's Thyroiditis |
National Taiwan University Hospital |
2014-04 | |
| NCT01634893 | COMPLETED | Refractory or Relapsed Solid Tumors |
The University of Texas Health Science Center at San Antonio |
2012-06 | PHASE1 |
| NCT02079077 | COMPLETED | HIV |
University of Manitoba |
2014-04 | |
| NCT02414776 | TERMINATED | Estrogen Receptor Positive Breast Cancer |
Western Regional Medical Center |
2014-07 | PHASE1 |
| NCT02475915 | COMPLETED | Acute HIV Infection |
SEARCH Research Foundation |
2015-01 | PHASE1; PHASE2 |
| NCT02351752 | COMPLETED | Primary IgA Nephropathy |
LLiu |
2015-01 | PHASE4 |
| NCT01784523 | TERMINATED | Antiphospholipid Syndrome |
Hospital for Special Surgery, New York |
2013-02 | PHASE3 |
| NCT02756546 | COMPLETED | Systemic Lupus Erythematosis |
Cairo University |
2014-09 | PHASE1; PHASE2 |
| NCT01006369 | COMPLETED | Colorectal Cancer |
Rutgers, The State University of New Jersey |
2009-05 | PHASE2 |
| NCT01687179 | COMPLETED | Lymphangioleiomyomatosis |
Brigham and Women's Hospital |
2012-09 | PHASE1 |
| NCT01649947 | COMPLETED | Non-small Cell Lung Cancer; Advanced Non-small Cell Lung Cancer; Recurrent Non-small Cell Lung Cancer |
Rutgers, The State University of New Jersey |
2011-12-23 | PHASE2 |
| NCT00977470 | ACTIVE_NOT_RECRUITING | Non-small Cell Lung Cancer |
Massachusetts General Hospital |
2009-10 | PHASE2 |
| NCT01495403 | COMPLETED | Liver Cirrhosis; Muscle Cramps |
Mayo Clinic |
2011-12 | EARLY_PHASE1 |
| NCT01709578 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2012-10 | PHASE3 |
| NCT02057250 | COMPLETED | RA |
Sanofi |
2014-03 | PHASE3 |
| NCT01842594 | TERMINATED | Sarcoma |
Shin Kong Wu Ho-Su Memorial Hospital |
2012-08 | PHASE2 |
| NCT00809237 | UNKNOWN | Non-small Cell Lung Cancer |
National University Hospital, Singapore |
2008-11 | PHASE1; PHASE2 |
| NCT01768572 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2013-03 | PHASE3 |
| NCT01232660 | UNKNOWN | HIV Infection |
St Stephens Aids Trust |
2010-10 | PHASE1 |
| NCT01417403 | TERMINATED | Bone Metastases; Unspecified Adult Solid Tumor, Protocol Specific |
Virginia Commonwealth University |
2011-08 | PHASE1 |
| NCT01148043 | COMPLETED | Osteoarthritis |
Maasstad Hospital |
2010-07 | PHASE3 |
| NCT01833845 | TERMINATED | Hepatitis C |
BioLineRx, Ltd. |
2013-04 | PHASE1; PHASE2 |
| NCT00726596 | COMPLETED | Prostate Cancer |
Rutgers, The State University of New Jersey |
2008-08 | PHASE2 |
| NCT01551069 | COMPLETED | Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus |
Sanofi |
2012-03 | PHASE3 |
| NCT01207739 | COMPLETED | Lyme Disease; Borrelia Infection |
Radboud University Medical Center |
2010-09 | PHASE4 |
| NCT01537315 | TERMINATED | Kidney Failure, Chronic; Cardiovascular Disease; Arteriosclerosis |
University of Arkansas |
2012-02 | PHASE2 |
| NCT01601028 | COMPLETED | Autoimmune Diseases; Sjogren's Syndrome; Dry Eye |
Seoul National University Hospital |
2011-07 | PHASE3 |
| NCT02200146 | COMPLETED | Pulmonary Sarcoidosis |
University of Milano Bicocca |
2009-03 | PHASE3 |
| NCT00486603 | COMPLETED | Brain and Central Nervous System Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-10-29 | PHASE1; PHASE2 |
| NCT00962845 | COMPLETED | Melanoma (Skin) |
Rutgers, The State University of New Jersey |
2010-09 | EARLY_PHASE1 |
| NCT01128296 | COMPLETED | Pancreatic Cancer |
Amer Zureikat |
2010-10 | PHASE1; PHASE2 |
| NCT00848354 | COMPLETED | Rheumatoid Arthritis |
Pfizer |
2009-06 | PHASE4 |
| NCT01326533 | COMPLETED | Pre-diabetes |
University of Pittsburgh |
2011-03 | PHASE4 |
| NCT01273805 | COMPLETED | Pancreatic Cancer |
Dana-Farber Cancer Institute |
2011-01 | PHASE2 |
| NCT01760421 | COMPLETED | Hashimoto Thyroiditis |
National Taiwan University Hospital |
2011-10 | |
| NCT01026844 | TERMINATED | Non-small Cell Lung Cancer |
Massachusetts General Hospital |
2007-07 | PHASE1 |
| NCT01040195 | COMPLETED | Seronegative Spondyloarthropathies |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2009-06 | PHASE3 |
| NCT01396200 | COMPLETED | Myeloma |
Abramson Cancer Center at Penn Medicine |
2011-06 | EARLY_PHASE1 |
| NCT00786682 | TERMINATED | Prostate Cancer |
University of Medicine and Dentistry of New Jersey |
2008-12 | PHASE2 |
| NCT01073852 | WITHDRAWN | Chronic Urticaria |
Vanderbilt University |
2011-06 | |
| NCT00909831 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Abramson Cancer Center at Penn Medicine |
2008-10 | PHASE1 |
| NCT01132118 | COMPLETED | Rheumatoid Arthritis; Insulin Resistance |
Brigham and Women's Hospital |
2010-06 | PHASE3 |
| NCT01227135 | UNKNOWN | Leukemia |
Lynn McMahon |
2010-03 | PHASE2 |
| NCT01272310 | UNKNOWN | Chronic Hepatitis C |
Sheba Medical Center |
2011-01 | PHASE1; PHASE2 |
| NCT00771056 | TERMINATED | B-Cell Chronic Lymphocytic Leukemia |
Northwell Health |
2008-07 | PHASE2 |
| NCT00765765 | TERMINATED | Breast Cancer |
University of Medicine and Dentistry of New Jersey |
2009-02 | PHASE1; PHASE2 |
| NCT00405275 | COMPLETED | Rheumatoid Arthritis |
US Department of Veterans Affairs |
2007-07 | |
| NCT00714181 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Abramson Cancer Center at Penn Medicine |
2008-06 | PHASE1 |
| NCT00568880 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Abramson Cancer Center at Penn Medicine |
2010-09-08 | PHASE1 |
| NCT00632866 | COMPLETED | Primary Sjögren's Syndrome |
Assistance Publique - Hôpitaux de Paris |
2008-03 | PHASE3 |
| NCT01067417 | UNKNOWN | HIV Infections |
Medical Research Council |
2008-06 | PHASE2 |
| NCT00413361 | COMPLETED | Systemic Lupus Erythematosus |
Assistance Publique - Hôpitaux de Paris |
2007-06 | PHASE4 |
| NCT00728845 | TERMINATED | Lung Cancer |
University of Medicine and Dentistry of New Jersey |
2008-06-16 | PHASE1; PHASE2 |
| NCT00579878 | COMPLETED | Rheumatoid Arthritis |
University of Nebraska |
2001-03-27 | PHASE3 |
| NCT00259610 | COMPLETED | Rheumatoid Arthritis |
University of Alabama at Birmingham |
2004-05 | PHASE4 |
| NCT00422227 | COMPLETED | Rheumatoid Arthritis |
Wyeth is now a wholly owned subsidiary of Pfizer |
2007-06 | PHASE4 |
| NCT00311883 | COMPLETED | Cystic Fibrosis |
Vanderbilt University |
2006-03 | PHASE1 |
| NCT00176982 | COMPLETED | Alopecia Areata |
Hordinsky, Maria K., MD |
2002-04 | PHASE4 |
| NCT00764725 | COMPLETED | Rheumatoid Arthritis |
Karolinska Institutet |
2002-12 | PHASE4 |
| NCT00031824 | COMPLETED | Graft Versus Host Disease |
Children's Oncology Group |
2002-04 | PHASE3 |
| NCT00430807 | COMPLETED | Giant Cell Arteritis |
University Hospital, Toulouse |
2002-01 | PHASE3 |
| NCT00946790 | COMPLETED | Immunosuppression; Rheumatism |
Sandoz |
1993-07 | PHASE1 |
| NCT00102557 | COMPLETED | Lichen Planus, Oral |
National Institute of Dental and Craniofacial Research (NIDCR) |
2005-01 | PHASE2 |
| NCT00089921 | COMPLETED | Arthritis, Rheumatoid |
Scios, Inc. |
2004-07 | PHASE2 |
(data from https://clinicaltrials.gov, updated on 2025-09-23)
Check the
HCQ (Hydroxychloroquine) Sulfate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- HCQ (Hydroxychloroquine) Sulfate Mechanism of Action: Endosome Inhibition in Viral Host Cell Research
- HCQ (Hydroxychloroquine) Sulfate: Selectivity & Specificity
- HCQ (Hydroxychloroquine) Sulfate Working Concentration | Cell Culture | Treatment
- HCQ (Hydroxychloroquine) Sulfate Solubility in DMSO
- HCQ (Hydroxychloroquine) Sulfate Stock Solution
- HCQ (Hydroxychloroquine) Sulfate Storage
- HCQ (Hydroxychloroquine) Sulfate Stability
- HCQ (Hydroxychloroquine) Sulfate Combination Database
- HCQ (Hydroxychloroquine) Sulfate Molecular Weight
- HCQ (Hydroxychloroquine) Sulfate SMILES
- HCQ (Hydroxychloroquine) Sulfate CAS Number
- HCQ (Hydroxychloroquine) Sulfate Chemical Structure (2D and 3D)
- HCQ (Hydroxychloroquine) Sulfate IC50 for Cell-based and Cell-free Assays
- HCQ (Hydroxychloroquine) Sulfate Sigma (H0915)? Try a better option.
- HCQ (Hydroxychloroquine) Sulfate Cayman (17911)? Try a better option.
- HCQ (Hydroxychloroquine) Sulfate APExBIO (B4874)? Try a better option.
- HCQ (Hydroxychloroquine) Sulfate MedChemExpress (HY-B1370)? Try a better option.
- HCQ (Hydroxychloroquine) Sulfate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.